Although they are not part of the five monocytic markers associated with MPAL classification in the WHO-HEM5 or the ICC guidelines, we frequently observe varying levels of CD11b, CD15, and CD36 expression, along with a notably bright intensity of CD33 on the monocytic components in MPAL. This evidence concerns the gene CD33 and mixed phenotype acute leukemia.